Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Glioma × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Vomiting 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thromboembolism 1 Stomatitis 1 Stomach Neoplasms 1 Spondylitis, Ankylosing 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Psoriasis 1 Postoperative Hemorrhage 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Pancreatic Cyst 1 Pain 1 Otolaryngeal Cancer 1 Leukemia 1 Kidney Neoplasms 1 Hyperparathyroidism 1

Interventions

Temozolomide 42 Bevacizumab 38 Radiotherapy 16 Magnetic Resonance Spectroscopy 12 Irinotecan 11 Nivolumab 7 Everolimus 6 Radiation 5 Carboplatin 5 poly ICLC 4 pembrolizumab 4 X-Rays 4 Phantoms, Imaging 4 Erlotinib Hydrochloride 4 Carmustine 4 ribociclib 3 fluorodopa F 18 3 Vorinostat 3 Specimen Handling 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3 Nuclear Medicine Department, Hospital 3 Modafinil 3 Lomustine 3 trametinib 2 selinexor 2 plerixafor 2 perampanel 2 palbociclib 2 lenvatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465268 2025-01-14

ATTAC-II

University of Florida

Phase 2 Completed

175 enrolled 18 charts

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡